Organogenesis Holdings
ORGO
124 hedge funds and large institutions have $162M invested in Organogenesis Holdings in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 36 increasing their positions, 46 reducing their positions, and 12 closing their positions.
133% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 12
21% more call options, than puts
Call options by funds: $122K | Put options by funds: $101K
15% more funds holding
Funds holding: 108 → 124 (+16)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11.02% less ownership
Funds ownership: 54.26% → 43.24% (-11%)
22% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 46
45% less capital invested
Capital invested by funds: $293M → $162M (-$131M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$2.21M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.07M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.6M |
| 4 |
AACP
Advantage Alpha Capital Partners
San Francisco,
California
|
+$1.35M |
| 5 |
HF
HRT Financial
New York
|
+$1.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$51.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.2M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$2.74M |
| 4 |
Millennium Management
New York
|
-$2.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.14M |
ORGO Hedge Fund Activity: Q1 2024 in Review
124 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q1 2024, worth a combined $162M — down 45% from $293M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new ORGO positions and 12 closed out — a net gain of 16 holders — while 36 added to existing stakes and 46 trimmed.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $2.21M. The largest seller was Morgan Stanley, cutting an estimated $51.7M.
- 124 institutional investors held Organogenesis Holdings (ORGO) as of Q1 2024, up from 108 in Q4 2023.
- Funds reported $162M of Organogenesis Holdings stock for Q1 2024, down 45% quarter-over-quarter.
- 28 funds opened new Organogenesis Holdings positions in Q1 2024 and 12 closed out, a net change of +16 holders.
- The largest Organogenesis Holdings buyer in Q1 2024 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $2.21M added.
- The largest Organogenesis Holdings seller in Q1 2024 was Morgan Stanley, an estimated $51.7M sold.
Based on aggregated 13F filings for Q1 2024.